The acute intermittent porphyria market is estimated to be valued at USD 1.43 Billion in 2024 and is expected to reach USD 2.17 Billion by 2031, growing at a compound annual growth rate (CAGR) of 6.1% from 2024 to 2031. https://www.zupyak.com/p/4476627/t/the-acute-intermittent-porphyria-market-is-to-witness-significant-growth-due-to-increasing-disease-prevalence